Results 161 to 170 of about 1,474,792 (282)

Development, system design, safety, and performance metrics of a conversational agent for reducing depressive and anxious symptoms based on a large language model: The MHAI study. [PDF]

PLoS One
Villarreal-Zegarra D, Paredes-Gonzales Y, Dámaso-Román A, Quiñones-Inga J, Centeno-Terrazas G, Lozada YPA.   +5 more
europepmc   +1 more source

Dual PI3K/AKT and CDK4/6 inhibition reveals selective sensitivity in an SHH medulloblastoma stem cell model

Molecular Oncology, EarlyView.
Targeted therapy was evaluated in SHH medulloblastoma using neuroepithelial stem cell (NES) and tumor‐derived NES‐like (tNES) models in 2D monolayers and 3D spheroids. PI3K, AKT, and CDK4/6 inhibitors had minimal effects in NES but markedly reduced viability and growth and induced apoptosis in tNES cells, revealing distinct therapeutic vulnerabilities.
Monika Lukoseviciute, Madeleine Birgersson, Paolo Ceriani, Margareta Wilhelm, Ourania N Kostopoulou   +4 more
wiley   +1 more source

Physical performance metrics of police officers in northeastern Mexico according to age groups and sex. [PDF]

Ann Occup Environ Med
Carranza-Garcia LE, Garcia-Flores I, Navarro-Orocio R, Lagunes-Carrasco JO, Lopez-Garcia R, Enriquez-Reyna MC.   +5 more
europepmc   +1 more source

Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy

Molecular Oncology, EarlyView.
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric, Line Bjørge, Martine Rott Lode, Cecilie Fredvik Torkildsen, Pia Aehnlich, Rammah Elnour, Daniela Elena Costea, Lars Andreas Akslen, Liv Cecilie Vestrheim Thomsen, Emmet McCormack, Katrin Kleinmanns   +10 more
wiley   +1 more source

A sustainability-oriented supply chain supplier selection framework using resilience and HSE performance metrics in the automotive industry. [PDF]

Sci Rep
Maddah S, Padash A, Hajiaghaei-Keshteli M, Bidhendi GRN, Taleizadeh AA, Borhani F.   +5 more
europepmc   +1 more source

Deciphering transcriptional plasticity in pancreatic ductal adenocarcinoma reveals alterations in sensory neuron innervation

Molecular Oncology, EarlyView.
Pancreatic sensory neurons innervating healthy and PDAC tissue were retrogradely labeled and profiled by single‐cell RNA sequencing. Tumor‐associated innervation showed a dominant neurofilament‐positive subtype, altered mitochondrial gene signatures, and reduced non‐peptidergic neurons.
Elena Genova, Michele Montrone, Uday Rangaswamy, Francesco Diversi, Irene Schiavo, Denise Ferrarini, Roberta Di Florio, Irene Longo, Michele Coscia, Nicola Zamboni, Giorgia Demontis, Lisa Veghini, Vincenzo Corbo, Remo Sanges, Paul Heppenstall   +14 more
wiley   +1 more source

Laypeople's Perceptions of Clinician Performance Metrics Based on Cancer Screening Attendance.

JAMA Health Forum
Scherer LD, Lewis CL, Cappella JN, McCaffery K, Hersch J, Morse B, Tate C, Parmet T, Mosley B, Smyth HL, Schapira MM.   +10 more
europepmc   +1 more source

A novel approach to monitoring selective fatigue in female softball athletes: evaluating load-velocity relationship variables and specific performance metrics. [PDF]

Front Physiol
Zhang H, Li Z, Yu Q, Cheng Z, Wang X, Zhang X, García-Ramos A, Janicijevic D.   +7 more
europepmc   +1 more source

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

Molecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera, Laura Vela‐Martín, Pablo Fernández‐Navarro, José Luis López‐Lorenzo, Javier Cornago, Pilar Llamas, Eduardo Pérez‐Gómez, José Luis Marín‐Rubio, Manuel Fresno, Javier Santos, José Fernández‐Piqueras, María Villa‐Morales   +11 more
wiley   +1 more source

Performance Metrics of Mammography Screening Programmes in Primary Health Care Centres in Bahrain. [PDF]

Int J Womens Health
Jassim GA, AlMohri MA, AlAsoomi HY, AlNooh A, AlDoseri SF.   +4 more
europepmc   +1 more source